臺灣癌症用藥事前審查實作指引
0.2.0 - ci-build

This page is part of the 臺灣癌症用藥事前審查實作指引(TWPAS IG) (v0.2.0: Releases) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example Observation: 檢驗檢查

狀態：final

類型：檢查報告 (NHI-補充資訊類別值集#examinationReport)

檢驗(查)名稱或套組代碼：Platelets [#/volume] in Blood by Automated count (LOINCCodes#777-3)

病人：Patient/pat-min

檢驗(查)報告日期：2024-01-01

簽發檢驗(查)報告醫事人員身分證號：Practitioner/pra-min

檢驗(查)結果：4.5 mmol/l

檢驗(查)檢驗(查)結果判讀：Positive (ObservationInterpretationCodes #POS)

檢驗(查)結果之參考範圍下限：2.9 mmol/L

檢驗(查)結果之參考範圍上限：4.9 mmol/L

檢驗(查)附件：DocumentReference/doc-test-min